Skip to main content
OpenTrials

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies
Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Active, Not Recruiting

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

NCT04554914

Conditions
Allogeneic Hematopoietic Cell Transplant, DNA Virus Infections, EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD), +24 more
Locations
  • University of California Los Angeles (UCLA) (Adults and Pediatrics) Los Angeles, California, United States
  • Children's Hospital of Orange County (Pediatrics [up to 25 years old]) Orange, California, United States
  • Lucile Packard Children's Hospital Stanford (Pediatrics only) Palo Alto, California, United States
  • University of California Davis Comprehensive Cancer Center (Adults and Pediatrics) Sacramento, California, United States
View all 40 locations
View Trial Details
Active, Not Recruiting

Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies

NCT04349436

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Cancer, +23 more
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California, San Diego La Jolla, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

NCT05020678

Conditions
Aggressive Lymphoma, B-cell Acute Lymphoblastic Leukemia, Blood Protein Disorders, +43 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • The Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Institute of Haematology, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • St. Vincent's Hospital Sydney, New South Wales, Australia
View Trial Details
Active, Not Recruiting

Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

NCT04291885

Conditions
Adenocarcinoma, Carcinoma, Carcinoma Neuroendocrine Skin, +18 more
Locations
  • Port Macquarie Base Hospital Port Macquarie, New South Wales, Australia
  • Chris O'Brien Lifehouse Sydney, New South Wales, Australia
  • Melanoma Institute Australia Sydney, New South Wales, Australia
  • Royal North Shore Hospital Sydney, New South Wales, Australia
View all 20 locations
View Trial Details
Active, Not Recruiting

A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

NCT04404660

Conditions
Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Diego Health (UCSD) La Jolla, California, United States
  • University of California Davis (UC Davis) Sacramento, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

NCT04792073

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

NCT01898494

Conditions
Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +28 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations

NCT03793140

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • City of Hope Duarte, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
View Trial Details

Related conditions